This week’s submission of ’52 Perspectives’ comes to us from Kurt Vorheis, Principal at V2 Bio-Consulting, Inc., a specialized consulting business providing operational expertise to BioPharma, Chemical, and Industrial companies. 1. Given the current state of the economy, what steps do you think are necessary for pharmaceutical companies to take with regard to outsourcing?
See more here:
The Economy, Patent Cliffs and Funding¦What™s a Pharmaco to do?
Related Posts:
Tags: biotech, chemical, consulting-business, current, economy, given-the-current, industrial, perspectives, principal, providing-operational, the-economy, vorheis, week
Categories : Biotechnology, Clinical Trials |
Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice